Bone morphogenetic protein 2 enhances PGE2-stimulated osteoclast formation in murine bone marrow cultures

Prostaglandins and Other Lipid Mediators

Volumn 90, Issue 3-4, 2009, Pages 76-80

  Blackwell, Katherine A ^a   Hortschansky, Peter ^b   Sanovic, Srdan ^a   Choudhary, Shilpa ^a   Raisz, Lawrence G ^a   Pilbeam, Carol C ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Bone marrow macrophage (BMM); Bone morphogenetic proteins; Cyclooxygenase 2 (COX 2); Macrophage colony stimulating factor (M CSF); Mice; Osteoclasts; Osteoprotegerin (OPG); Prostaglandin; Receptor activator of NF B ligand (RANKL)

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; PROTEIN EXPRESSION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL COUNT; CELLS, CULTURED; DINOPROSTONE; HUMANS; MACROPHAGES; MICE; OSTEOCLASTS; OSTEOPROTEGERIN; RANK LIGAND; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 71549169272     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2009.08.005     Document Type: Article

References (36)

1. Wang E.A., Rosen V., D'Alessandro J.S., et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87 (1990) 2220
2. Chikazu D., Li X., Kawaguchi H., et al. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 17 (2002) 1430
3. Schmidmaier G., and Wildemann B. The role of BMPs in current orthopedic practice. IBMS BoneKEy 6 (2009) 244
4. Sasaoka R., Terai H., Toyoda H., Imai Y., Sugama R., and Takaoka K. A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 318 (2004) 704
5. Toyoda H., Terai H., Sasaoka R., Oda K., and Takaoka K. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone 37 (2005) 555
6. Namikawa T., Terai H., Hoshino M., et al. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model. Spine 32 (2007) 2294
7. 2, or parathyroid hormone in the microenvironment of bone. Biochem Biophys Res Commun 246 (1998) 337
8. 2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 30 (2002) 567
9. 2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 172 (2004) 2504
10. Otsuka E., Notoya M., and Hagiwara H. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int 73 (2003) 72
11. Koide M., Murase Y., Yamato K., Noguchi T., Okahashi N., and Nishihara T. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2. Biochem Biophys Res Commun 259 (1999) 97
12. Abe E., Yamamoto M., Taguchi Y., et al. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15 (2000) 663
13. Itoh K., Udagawa N., Katagiri T., et al. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142 (2001) 3656
14. Okamoto M., Murai J., Yoshikawa H., and Tsumaki N. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res 21 (2006) 1022
15. Ghosh-Choudhury N., Singha P.K., Woodruff K., et al. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression. J Biol Chem 281 (2006) 20160
16. Susperregui A.R., Vinals F., Ho P.W., Gillespie M.T., Martin T.J., and Ventura F. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells. J Cell Physiol 216 (2008) 144
17. Wan C., He Q., and Li G. Osteoclastogenesis in the nonadherent cell population of human bone marrow is inhibited by RhBMP-2 alone or together with RhVEGF. J Orthop Res 24 (2006) 29
18. Wan M., Shi X., Feng X., and Cao X. Transcriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expression. J Biol Chem 276 (2001) 10119
19. Sachse A., Wagner A., Keller M., et al. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 37 (2005) 699
20. Tomita M., Li X., Okada Y., et al. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone 30 (2002) 159
21. Li X., Okada Y., Pilbeam C.C., et al. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 141 (2000) 2054
22. Epple H., Cremasco V., Zhang K., Mao D., Longmore G.D., and Faccio R. Phospholipase Cgamma2 modulates integrin signaling in the osteoclast by affecting the localization and activation of Src kinase. Mol Cell Biol 28 (2008) 3610
23. 2α on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res 6 (1991) 157
24. 2 stimulated osteoclastogenesis. J Bone Miner Res 23 (2008) S263
25. Okada Y., Lorenzo J.A., Freeman A.M., et al. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 105 (2000) 823
26. Rodriguez JS, Mansky KC, Jensen ED, et al. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling. J Bone Miner Res; in press, doi:10.1359/jbmr.090507.
27. Koseki T., Gao Y., Okahashi N., et al. Role of TGF-beta family in osteoclastogenesis induced by RANKL. Cell Signal 14 (2002) 31
28. Akchurin T., Aissiou T., Kemeny N., Prosk E., Nigam N., and Komarova S.V. Complex dynamics of osteoclast formation and death in long-term cultures. PLoS One 3 (2008) e2104
29. 2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 20 (2005) 23
30. Fujita K., and Janz S. Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. Mol Cancer 6 (2007) 71
31. Usui M., Xing L., Drissi H., et al. Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2. J Bone Miner Res 23 (2008) 314
32. Koga T., Inui M., Inoue K., et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428 (2004) 758
33. Hofbauer L.C., Dunstan C.R., Spelsberg T.C., Riggs B.L., and Khosla S. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. Biochem Biophys Res Commun 250 (1998) 776
34. Poynton A.R., and Lane J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27 (2002) S40
35. Hansen S.M., and Sasso R.C. Resorptive response of RhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring. J Spinal Disord Tech 19 (2006) 130
36. Lewandrowski K.U., Nanson C., and Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J 7 (2007) 609